The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer. par Øystein Helland, Mihaela Popa, Katharina Bischof, Bjørn Tore Gjertsen, Emmet McCormack, Line Bjørge

Accéder au texte intégral

First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. par Oystein Helland, Mihaela Popa, Olav K Vintermyr, Anders Molven, Bjørn Tore Gjertsen, Line Bjørge, Emmet McCormack

Accéder au texte intégral

CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model par Katrin Kleinmanns, Vibeke Fosse, Ben Davidson, Elvira García de Jalón, Olav Tenstad, Line Bjørge, Emmet McCormack

Accéder au texte intégral

9 Advanced orthotopic ovarian cancer patient-derived xenograft models for improved preclinical evaluation of immunotherapies par Line Bjorge, Sébastien Wälchli, Emmet McCormack, Katrin Kleinmanns, Luka Tandaric, Martine Lode, Stein-Erik Gullaksen, Nicholas Casey

Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration par Eirik Tveit Solheim, Liv Cecilie Vestrheim Thomsen, Line Bjørge, Shamundeeswari Anandan, Elise Peter, Virginie Desestret, Cecilie Totland, Christian A. Vedeler

Accéder au texte intégral

Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways par Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise‐Lotte Flage‐Larsen, Alexandra Gade, Line Bjørge, Alfonso Urbanucci, Kjetil Taskén

Accéder au texte intégral

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high‐grade serous ovarian carcinomas par Cecilie Fredvik Torkildsen, Liv Cecilie Vestrheim Thomsen, Ragnar Kvie Sande, Camilla Krakstad, Ingunn Stefansson, Eva Karin Lamark, Stian Knappskog, Line Bjørge

Accéder au texte intégral

New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients par Cecilie Fredvik Torkildsen, Cecilie Fredvik Torkildsen, Marie Austdal, Anders Hagen Jarmund, Katrin Kleinmanns, Katrin Kleinmanns, Eva Karin Lamark, Elisabeth Berge Nilsen, Ingunn Stefansson, Ingunn Stefansson, Ragnar Kvie Sande, Ragnar Kvie Sande, Ann-Charlotte Iversen, Liv Cecilie Vestrheim Thomsen, Liv Cecilie Vestrheim Thomsen, Line Bjørge, Line Bjørge

Accéder au texte intégral

CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma par Katrin Kleinmanns, Katharina Bischof, Shamundeeswari Anandan, Mihaela Popa, Lars A. Akslen, Vibeke Fosse, Ida Tveit Karlsen, Bjørn T. Gjertsen, Line Bjørge, Emmet McCormack

Accéder au texte intégral

High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma par Katharina Bischof, Stian Knappskog, Ingunn Stefansson, Emmet Martin McCormack, Jone Trovik, Henrica Maria Johanna Werner, Kathrine Woie, Bjorn Tore Gjertsen, Line Bjorge

Accéder au texte intégral

Cholesterol Crystals and NLRP3 Mediated Inflammation in the Uterine Wall Decidua in Normal and Preeclamptic Pregnancies par Gabriela Brettas Silva, Gabriela Brettas Silva, Lobke Marijn Gierman, Lobke Marijn Gierman, Johanne Johnsen Rakner, Guro Sannerud Stødle, Siv Boon Mundal, Astrid Josefin Thaning, Bjørnar Sporsheim, Mattijs Elschot, Mattijs Elschot, Karin Collett, Line Bjørge, Line Bjørge, Marie Hjelmseth Aune, Liv Cecilie Vestrheim Thomsen, Liv Cecilie Vestrheim Thomsen, Ann-Charlotte Iversen, Ann-Charlotte Iversen

Accéder au texte intégral

C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease. par Johannes Landskron, Sigrid M Kraggerud, Elisabeth Wik, Anne Dørum, Merete Bjørnslett, Espen Melum, Øystein Helland, Line Bjørge, Ragnhild A Lothe, Helga B Salvesen, Kjetil Taskén

Accéder au texte intégral

Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes par Maria Grazia Perrone, Paola Vitale, Morena Miciaccia, Savina Ferorelli, Antonella Centonze, Roberta Solidoro, Cristina Munzone, Carmela Bonaccorso, Cosimo Gianluca Fortuna, Katrin Kleinmanns, Line Bjørge, Antonio Scilimati

Accéder au texte intégral

Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins par Cecilie Fredvik Torkildsen, Marie Austdal, Ann-Charlotte Iversen, Tone Frost Bathen, Guro Fanneløb Giskeødegård, Elisabeth Berge Nilsen, Grete Alræk Iversen, Ragnar Kvie Sande, Line Bjørge, Liv Cecilie Vestrheim Thomsen

Accéder au texte intégral

Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study. par Tormund S Njølstad, Henrica M Werner, Janusz Marcickiewicz, Solveig Tingulstad, Anne C Staff, Klaus Oddenes, Line Bjørge, Marie E Engh, Kathrine Woie, Jostein Tjugum, Margaret S Lode, Frederic Amant, Helga B Salvesen, Jone Trovik

Accéder au texte intégral

Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock par James E. Barrett, Chiara Herzog, Yoo-Na Kim, Thomas E. Bartlett, Allison Jones, Iona Evans, David Cibula, Michal Zikan, Line Bjørge, Nadia Harbeck, Nicoletta Colombo, Sacha J. Howell, Angelique Flöter Rådestad, Kristina Gemzell-Danielsson, Martin Widschwendter

Accéder au texte intégral

Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock par J. James E. Barrett, Chiara Herzog, Yoo-Na Kim, Thomas E. Bartlett, Allison Jones, Iona Evans, David Cibula, Michal Zikan, Line Bjørge, Nadia Harbeck, Nicoletta Colombo, Sacha J. Howell, Angelique Flöter Rådestad, Kristina Gemzell-Danielsson, Martin Widschwendter

Accéder au texte intégral

Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16 par Gunnar Kvalheim, Kristina Lindemann, Ben Davidson, Line Bjorge, Else Marit Inderberg, Sébastien Wälchli, Emmet McCormack, Katrin Kleinmanns, David J Warren, Erik Rokkones, Martine Lode, Nicholas P Casey, Christopher Forcados, Pascal F Gelebart, Sandy Joaquina, Emmanuelle Benard, Fatemeh Kaveh, Benjamin Caulier, Christiane Helgestad Gjerde, Elvira García de Jalón, Marit Renee Myhre

Accéder au texte intégral

The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples par James E. Barrett, Chiara Herzog, Allison Jones, Olivia C. Leavy, Iona Evans, Susanne Knapp, Daniel Reisel, Tatiana Nazarenko, Yoo-Na Kim, Dorella Franchi, Andy Ryan, Joanna Franks, Line Bjørge, Michal Zikan, David Cibula, Nadia Harbeck, Nicoletta Colombo, Frank Dudbridge, Louise Jones, Karin Sundström, Joakim Dillner, Angelique Flöter Rådestad, Kristina Gemzell-Danielsson, Nora Pashayan, Martin Widschwendter

Accéder au texte intégral

IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results par Katarina Puco, Gro Live Fagereng, Sigmund Brabrand, Pitt Niehusmann, Egil Støre Blix, Eli Sihn Samdal Steinskog, Åse Haug, Cecilie Fredvik Torkildsen, Irja Alida Oppedal, Sebastian Meltzer, Åsmund Flobak, Kajsa Anna Margareta Johansson, Line Bjørge, Geir Olav Hjortland, Astrid Dalhaug, Jo-Åsmund Lund, Bjørnar Gilje, Marte Grønlie Cameron, Randi Hovland, Ragnhild S. Falk, Sigbjørn Smeland, Hege Elisabeth Giercksky Russnes, Kjetil Taskén, Åslaug Helland

Accéder au texte intégral